A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

Guillermo Garcia‐Manero, Nikolai A. Podoltsev, Megan Othus, John M. Pagel, Jerald P. Radich, Min Fang, David A. Rizzieri, Guido Marcucci, Stephen A. Strickland, Mark R. Litzow, Mary Lynn Savoie, Bruno C. Medeiros, Mikkael A. Sekeres, Tara L. Lin, Geoffrey L. Uy, Bayard L. Powell, Jonathan E. Kolitz, Richard A. Larson, Richard M. Stone, David F. Claxton, James Essell, Selina M. Luger, Sanjay Mohan, Anna Moseley, Frederick R. Appelbaum, Harry P. Erba